Replies to post #14566 on Delcath Systems Inc (DCTH)

[24x7]

WarChest,

Love your insights. I feel this company has long term in it. With great products and finely FDA phase III approval. 29 million cash on hand, 2.3 million in EU sales and growing, and a 9 million a year cost of operations. Having said this I'm in @ .02 with DCTH and I'm happy. I got my 100% (x2) out and the rest I'm hanging with, Hopefully not by a noose. I think she has room for $1.24 - $3+ over the next 52.

[jlee3]

In 2010 there were ~40 million shares outstanding. If they got bought out around $16 per share that'd be 640M, no? and if they get bought out in the next few weeks with 500M shares outstanding for $1.28/share that would also be 640 million